Andrea Camerini (A Camerini)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Electronic Health Record

Top Venues

Journal of clinical medicine

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Camerini, Francesca Mazzoni, Vieri Scotti, Carmelo Tibaldi, Andrea Sbrana, Luana Calabrò, Enrico Caliman, Lucia Pia Ciccone, Laura Bernardini, Jessica Graziani, Maria Antonietta Grosso, Antonio Chella, Giacomo Allegrini, Domenico Amoroso, Editta Baldini
Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Journal of clinical medicine 13 (13) (2024)
Andrea Camerini, Francesca Mazzoni, Vieri Scotti, Carmelo Tibaldi, Andrea Sbrana, Luana Calabrò, Enrico Caliman, Lucia Pia Ciccone, Laura Bernardini, Jessica Graziani, Maria Antonietta Grosso, Antonio Chella, Giacomo Allegrini, Domenico Amoroso, Editta Baldini
Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Journal of clinical medicine 13 (13) (2024)
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Lucia Pia Ciccone, Marco Perna, Giulia Sartori, Cheti Puccetti, Alberto Ricci, Antonio Santo, Marcello Tiseo, Domenico Amoroso
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial. Cancers 14 (24) (2022)
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Lucia Pia Ciccone, Marco Perna, Giulia Sartori, Cheti Puccetti, Alberto Ricci, Antonio Santo, Marcello Tiseo, Domenico Amoroso
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial. Cancers 14 (24) (2022)
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Lucia Pia Ciccone, Marco Perna, Giulia Sartori, Cheti Puccetti, Alberto Ricci, Antonio Santo, Marcello Tiseo, Domenico Amoroso
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial. Cancers 14 (24) (2022)
Maria Laura Canale, Andrea Camerini, Giancarlo Casolo, Alessio Lilli, Irma Bisceglia, Iris Parrini, Chiara Lestuzzi, Jacopo Del Meglio, Cheti Puccetti, Lara Camerini, Domenico Amoroso, Nicola Maurea
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy. Advances in therapy 37 (7) (2020)
Andrea Camerini, G L Banna, S Cinieri, A Pezzuto, M Mencoboni, F Rosetti, A Figueiredo, P Rizzo, A Ricci, L Langenhoven, A Santo, A Addeo, D Amoroso, F Barata
Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (6) (2018)